$CPIX
CUMBERLAND PHARMACEUTICALS INC Stock $cpix

$cpix Overview Financials Valuation SEC Filings Company Website

2017 Q4 Form 10-K Financial Statement

#000162828019002785 Filed on March 12, 2019

Income Statement

Concept	2017 Q4	2017 Q3	2017 Q2
Revenue	$11.65M	$11.20M	$8.667M
YoY Change	28.28%	27.36%	16.89%
Cost Of Revenue	$2.150M	$2.166M	$1.669M
YoY Change	33.54%	9.75%	44.46%
Gross Profit	$9.500M	$9.031M	$6.998M
YoY Change	27.01%	32.46%	11.8%
Gross Profit Margin	81.55%	80.65%	80.74%
Selling, General & Admin	$8.790M	$8.317M	$7.008M
YoY Change	31.0%	51.77%	36.17%
% of Gross Profit	92.53%	92.1%	100.14%
Research & Development	$980.0K	$943.2K	$1.080M
YoY Change	-15.52%	46.3%	59.17%
% of Gross Profit	10.32%	10.44%	15.44%
Depreciation & Amortization	$680.0K	$660.0K	$650.0K
YoY Change	11.48%	6.45%	10.17%
% of Gross Profit	7.16%	7.31%	9.29%
Operating Expenses	$10.40M	$9.260M	$8.088M
YoY Change	23.37%	51.19%	38.85%
Operating Profit	-$903.3K	-$839.3K	-$1.681M
YoY Change	-5.65%	-745.0%	1496.13%
Interest Expense	$60.00K	$8.902K	$30.03K
YoY Change	200.0%	-69.4%	6.31%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	-$840.0K	-$753.4K	-$1.641M
YoY Change	-10.64%	-593.46%	1508.08%
Income Tax	$80.00K	$3.822K	$3.536M
% Of Pretax Income
Net Earnings	-$800.5K	-$743.0K	-$5.161M
YoY Change	6.78%	-799.88%	10641.43%
Net Earnings / Revenue	-6.87%	-6.64%	-59.54%
Basic Earnings Per Share	-$0.05	-$0.05	-$0.32
Diluted Earnings Per Share	-$0.05	-$0.05	-$0.32
COMMON SHARES
Basic Shares Outstanding	15.75M shares	15.87M shares	16.01M shares
Diluted Shares Outstanding		15.87M shares	16.01M shares

Balance Sheet

Concept	2017 Q4	2017 Q3	2017 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$50.09M	$50.07M	$48.97M
YoY Change	-0.09%	-0.14%	-2.84%
Cash & Equivalents	$45.41M	$42.02M	$34.62M
Short-Term Investments	$4.672M	$8.055M	$14.36M
Other Short-Term Assets	$3.467M	$2.946M	$2.659M
YoY Change	27.87%	-42.92%	-35.4%
Inventory	$6.738M	$5.857M	$5.554M
Prepaid Expenses
Receivables	$8.395M	$7.205M	$6.107M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$68.68M	$66.08M	$63.29M
YoY Change	4.79%	-1.31%	-1.09%
LONG-TERM ASSETS
Property, Plant & Equipment	$528.9K	$474.7K	$495.3K
YoY Change	13.87%	-1.63%	-2.04%
Goodwill	$0.00
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$2.487M	$2.253M	$2.202M
YoY Change	17.26%	-8.26%	-12.26%
Total Long-Term Assets	$24.55M	$24.27M	$24.51M
YoY Change	-11.89%	0.65%	2.56%
TOTAL ASSETS
Total Short-Term Assets	$68.68M	$66.08M	$63.29M
Total Long-Term Assets	$24.55M	$24.27M	$24.51M
Total Assets	$93.23M	$90.35M	$87.80M
YoY Change	-0.18%	-0.79%	-0.1%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$8.980M	$7.922M	$6.412M
YoY Change	11.74%	18.98%	74.82%
Accrued Expenses	$8.715M
YoY Change	29.0%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$17.69M	$15.80M	$12.98M
YoY Change	19.62%	35.19%	45.93%
LONG-TERM LIABILITIES
Long-Term Debt	$9.800M	$8.000M	$6.700M
YoY Change	139.02%	116.22%	91.43%
Other Long-Term Liabilities	$1.816M	$1.600M	$1.600M
YoY Change	30.51%	23.08%	45.45%
Total Long-Term Liabilities	$1.816M	$9.600M	$8.300M
YoY Change	30.51%	92.0%	80.43%
TOTAL LIABILITIES
Total Short-Term Liabilities	$17.69M	$15.80M	$12.98M
Total Long-Term Liabilities	$1.816M	$9.600M	$8.300M
Total Liabilities	$29.31M	$25.43M	$21.31M
YoY Change	44.5%	52.74%	57.68%
SHAREHOLDERS EQUITY
Retained Earnings	$11.71M	$12.51M	$13.25M
YoY Change	-37.06%	-35.37%	-31.15%
Common Stock	$52.41M	$52.59M	$53.40M
YoY Change	-4.09%	-4.69%	-3.29%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$64.12M	$65.10M	$66.66M
YoY Change
Total Liabilities & Shareholders Equity	$93.23M	$90.35M	$87.80M
YoY Change	-0.18%	-0.79%	-0.1%

Cashflow Statement

Concept	2017 Q4	2017 Q3	2017 Q2
OPERATING ACTIVITIES
Net Income	-$800.5K	-$743.0K	-$5.161M
YoY Change	6.78%	-799.88%	10641.43%
Depreciation, Depletion And Amortization	$680.0K	$660.0K	$650.0K
YoY Change	11.48%	6.45%	10.17%
Cash From Operating Activities	-$460.0K	$990.0K	-$2.530M
YoY Change	-156.1%	241.38%	121.93%
INVESTING ACTIVITIES
Capital Expenditures	-$480.0K	-$110.0K	-$320.0K
YoY Change	0.0%	-78.0%	-28.89%
Acquisitions
YoY Change
Other Investing Activities	$3.380M	$6.340M	$1.130M
YoY Change	-434.65%	-31800.0%	264.52%
Cash From Investing Activities	$2.910M	$6.210M	$820.0K
YoY Change	-294.0%	-1294.23%	-646.67%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	940.0K	200.0K	1.360M
YoY Change	-361.11%	-385.71%	97.1%
NET CHANGE
Cash From Operating Activities	-460.0K	990.0K	-2.530M
Cash From Investing Activities	2.910M	6.210M	820.0K
Cash From Financing Activities	940.0K	200.0K	1.360M
Net Change In Cash	3.390M	7.400M	-350.0K
YoY Change	-425.96%	-2566.67%	-41.67%
FREE CASH FLOW
Cash From Operating Activities	-$460.0K	$990.0K	-$2.530M
Capital Expenditures	-$480.0K	-$110.0K	-$320.0K
Free Cash Flow	$20.00K	$1.100M	-$2.210M
YoY Change	-98.46%	39.24%	220.29%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2018	dei	Entity Central Index Key EntityCentralIndexKey	0001087294
CY2018	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2018	dei	Document Period End Date DocumentPeriodEndDate	2018-12-31
CY2018	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2018
CY2018	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2018	dei	Amendment Flag AmendmentFlag	false
CY2018	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2018	dei	Entity Small Business EntitySmallBusiness	false
CY2018	dei	Entity Shell Company EntityShellCompany	false
CY2018	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2018	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2018	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2018	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2018Q4	us-gaap	Common Stock No Par Value CommonStockNoParValue	0
CY2017Q4	us-gaap	Common Stock No Par Value CommonStockNoParValue	0
CY2018Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2017Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2018Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	15723075	shares
CY2017Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	16074176	shares
CY2018Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	15723075	shares
CY2017Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	16074176	shares
CY2017	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	50000	USD
CY2016	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	50000	USD
CY2018	dei	Document Type DocumentType	10-K
CY2018	dei	Entity Registrant Name EntityRegistrantName	CUMBERLAND PHARMACEUTICALS INC
CY2018Q2	dei	Entity Public Float EntityPublicFloat	58282085	USD
CY2019Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	15447413	shares
CY2018Q1	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	17000000.0	USD
CY2018Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	15900000	USD
CY2018Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	27938960	USD
CY2017Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	45412868	USD
CY2018Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	8290679	USD
CY2017Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	4672476	USD
CY2018Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	7844249	USD
CY2017Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	8395112	USD
CY2018Q4	us-gaap	Inventory Net InventoryNet	12078343	USD
CY2017Q4	us-gaap	Inventory Net InventoryNet	6737848	USD
CY2018Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2963806	USD
CY2017Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3466541	USD
CY2018Q4	us-gaap	Assets Current AssetsCurrent	59116037	USD
CY2017Q4	us-gaap	Assets Current AssetsCurrent	68684845	USD
CY2018Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	771213	USD
CY2017Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	528882	USD
CY2018Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	33655099	USD
CY2017Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	21444545	USD
CY2018Q4	us-gaap	Goodwill Goodwill	784000	USD
CY2017Q4	us-gaap	Goodwill Goodwill	0	USD
CY2018Q4	us-gaap	Deferred Tax Assets Liabilities Net Noncurrent DeferredTaxAssetsLiabilitiesNetNoncurrent	87210	USD
CY2017Q4	us-gaap	Deferred Tax Assets Liabilities Net Noncurrent DeferredTaxAssetsLiabilitiesNetNoncurrent	87210	USD
CY2018Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2531309	USD
CY2017Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2486830	USD
CY2018Q4	us-gaap	Assets Assets	112693868	USD
CY2017Q4	us-gaap	Assets Assets	93232312	USD
CY2018Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	11093297	USD
CY2017Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	8979929	USD
CY2018Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	16710927	USD
CY2017Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	8714814	USD
CY2018Q4	us-gaap	Liabilities Current LiabilitiesCurrent	27804224	USD
CY2017Q4	us-gaap	Liabilities Current LiabilitiesCurrent	17694743	USD
CY2018Q4	us-gaap	Long Term Line Of Credit LongTermLineOfCredit	20000000	USD
CY2017Q4	us-gaap	Long Term Line Of Credit LongTermLineOfCredit	9800000	USD
CY2018Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	9319143	USD
CY2017Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1815968	USD
CY2018Q4	us-gaap	Liabilities Liabilities	57123367	USD
CY2017Q4	us-gaap	Liabilities Liabilities	29310711	USD
CY2018Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2018	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-550863	USD
CY2017Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2018Q4	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	51098613	USD
CY2017Q4	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	52410941	USD
CY2018Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	4746154	USD
CY2017Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	11709222	USD
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	55844767	USD
CY2017Q4	us-gaap	Stockholders Equity StockholdersEquity	64120163	USD
CY2018Q4	us-gaap	Minority Interest MinorityInterest	-274266	USD
CY2017Q4	us-gaap	Minority Interest MinorityInterest	-198562	USD
CY2018Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	55570501	USD
CY2017Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	63921601	USD
CY2018Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	112693868	USD
CY2017Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	93232312	USD
CY2018	us-gaap	Revenues Revenues	40741765	USD
CY2017	us-gaap	Revenues Revenues	41150131	USD
CY2016	us-gaap	Revenues Revenues	33025560	USD
CY2018	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	7378095	USD
CY2017	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	7370585	USD
CY2016	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	5958660	USD
CY2018	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	20258307	USD
CY2017	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	21492937	USD
CY2016	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	14553481	USD
CY2018	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	7320797	USD
CY2017	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3901365	USD
CY2016	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3190700	USD
CY2018	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	10405872	USD
CY2017	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	10030370	USD
CY2016	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	8561811	USD
CY2018	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2769466	USD
CY2017	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2436222	USD
CY2016	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2194039	USD
CY2018	us-gaap	Costs And Expenses CostsAndExpenses	48132537	USD
CY2017	us-gaap	Costs And Expenses CostsAndExpenses	45231479	USD
CY2016	us-gaap	Costs And Expenses CostsAndExpenses	34458691	USD
CY2018	us-gaap	Operating Income Loss OperatingIncomeLoss	-7390772	USD
CY2017	us-gaap	Operating Income Loss OperatingIncomeLoss	-4081348	USD
CY2016	us-gaap	Operating Income Loss OperatingIncomeLoss	-1433131	USD
CY2018	us-gaap	Investment Income Interest InvestmentIncomeInterest	564484	USD
CY2017	us-gaap	Investment Income Interest InvestmentIncomeInterest	299326	USD
CY2016	us-gaap	Investment Income Interest InvestmentIncomeInterest	204661	USD
CY2018	us-gaap	Interest Expense InterestExpense	195848	USD
CY2017	us-gaap	Interest Expense InterestExpense	92904	USD
CY2016	us-gaap	Interest Expense InterestExpense	106392	USD
CY2018	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-7022136	USD
CY2017	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-3874926	USD
CY2016	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-1334862	USD
CY2018	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	16636	USD
CY2017	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	4174889	USD
CY2016	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-330924	USD
CY2018	us-gaap	Profit Loss ProfitLoss	-7038772	USD
CY2017	us-gaap	Profit Loss ProfitLoss	-8049815	USD
CY2016	us-gaap	Profit Loss ProfitLoss	-1003938	USD
CY2018	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-75704	USD
CY2017	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-71182	USD
CY2016	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-59255	USD
CY2018	us-gaap	Net Income Loss NetIncomeLoss	-6963068	USD
CY2017	us-gaap	Net Income Loss NetIncomeLoss	-7978633	USD
CY2016	us-gaap	Net Income Loss NetIncomeLoss	-944683	USD
CY2018	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.45
CY2017	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.50
CY2016	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.06
CY2018	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.45
CY2017	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.50
CY2016	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.06
CY2018	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	15614052	shares
CY2017	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	15911577	shares
CY2016	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	16236525	shares
CY2018	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	15614052	shares
CY2017	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	15911577	shares
CY2016	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	16236525	shares
CY2018	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-6963068	USD
CY2017	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-7978633	USD
CY2016	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-944683	USD
CY2018	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest	-75704	USD
CY2017	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest	-71182	USD
CY2016	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest	-59255	USD
CY2018	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-7038772	USD
CY2017	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-8049815	USD
CY2016	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-1003938	USD
CY2018	us-gaap	Profit Loss ProfitLoss	-7038772	USD
CY2017	us-gaap	Profit Loss ProfitLoss	-8049815	USD
CY2016	us-gaap	Profit Loss ProfitLoss	-1003938	USD
CY2018	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2982703	USD
CY2017	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2647753	USD
CY2016	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2396908	USD
CY2018	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	81886	USD
CY2017	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	4206753	USD
CY2016	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	619580	USD
CY2018	us-gaap	Share Based Compensation ShareBasedCompensation	1364698	USD
CY2017	us-gaap	Share Based Compensation ShareBasedCompensation	1115063	USD
CY2016	us-gaap	Share Based Compensation ShareBasedCompensation	852102	USD
CY2018	cpix	Sharebased Compensation Foundation Contribution SharebasedCompensationFoundationContribution	0	USD
CY2017	cpix	Sharebased Compensation Foundation Contribution SharebasedCompensationFoundationContribution	372500	USD
CY2016	cpix	Sharebased Compensation Foundation Contribution SharebasedCompensationFoundationContribution	0	USD
CY2018	us-gaap	Excess Tax Benefit From Share Based Compensation Operating Activities ExcessTaxBenefitFromShareBasedCompensationOperatingActivities	81886	USD
CY2017	us-gaap	Excess Tax Benefit From Share Based Compensation Operating Activities ExcessTaxBenefitFromShareBasedCompensationOperatingActivities	91109	USD
CY2016	us-gaap	Excess Tax Benefit From Share Based Compensation Operating Activities ExcessTaxBenefitFromShareBasedCompensationOperatingActivities	-1026413	USD
CY2018	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	99883	USD
CY2017	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	77911	USD
CY2016	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	84539	USD
CY2018	us-gaap	Other Nonoperating Gains Losses OtherNonoperatingGainsLosses	168440	USD
CY2017	us-gaap	Other Nonoperating Gains Losses OtherNonoperatingGainsLosses	52012	USD
CY2016	us-gaap	Other Nonoperating Gains Losses OtherNonoperatingGainsLosses	74015	USD
CY2017	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1064985	USD
CY2016	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1253007	USD
CY2018	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-460505	USD
CY2017	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1366118	USD
CY2016	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1101586	USD
CY2018	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-712149	USD
CY2017	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	1074369	USD
CY2016	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	1556282	USD
CY2018	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	4308706	USD
CY2017	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	2307617	USD
CY2016	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	191901	USD
CY2018	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-159558	USD
CY2017	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	413097	USD
CY2016	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	386863	USD
CY2018	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	3112737	USD
CY2017	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-557714	USD
CY2016	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	569478	USD
CY2018	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	455569	USD
CY2017	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	275960	USD
CY2016	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	130872	USD
CY2018	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	3819486	USD
CY2017	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	1213110	USD
CY2016	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	2000226	USD
CY2018	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	20000000	USD
CY2017	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	0	USD
CY2016	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	0	USD
CY2018	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	16663232	USD
CY2017	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	13381061	USD
CY2016	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	4489111	USD
CY2018	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	20112995	USD
CY2017	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	2379414	USD
CY2016	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	5473092	USD
CY2018	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-27724818	USD
CY2017	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	9512577	USD
CY2016	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3115079	USD
CY2018	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	56000000	USD
CY2017	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	24500000	USD
CY2016	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	2400000	USD
CY2018	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	45800000	USD
CY2017	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	18800000	USD
CY2016	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	0	USD
CY2018	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	2879426	USD
CY2017	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	3724375	USD
CY2016	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	2520715	USD
CY2018	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	383310	USD
CY2017	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	27950	USD
CY2016	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	0	USD
CY2018	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	200909	USD
CY2017	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	USD
CY2016	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	USD
CY2018	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	0	USD
CY2017	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	0	USD
CY2016	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	-1026413	USD
CY2018	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	7138173	USD
CY2017	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1947675	USD
CY2016	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1147128	USD
CY2018	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-17473908	USD
CY2017	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	10902538	USD
CY2016	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-3692729	USD
CY2017Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	45412868	USD
CY2016Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	34510330	USD
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	38203059	USD
CY2018Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	27938960	USD
CY2017Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	45412868	USD
CY2016Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	34510330	USD
CY2018	us-gaap	Interest Paid InterestPaid	95965	USD
CY2017	us-gaap	Interest Paid InterestPaid	14993	USD
CY2016	us-gaap	Interest Paid InterestPaid	21853	USD
CY2018	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	15441	USD
CY2017	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	18000	USD
CY2016	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	-8359	USD
CY2018	cpix	Purchases Of Intangible Assets Incurred But Not Yet Paid PurchasesOfIntangibleAssetsIncurredButNotYetPaid	-539467	USD
CY2017	cpix	Purchases Of Intangible Assets Incurred But Not Yet Paid PurchasesOfIntangibleAssetsIncurredButNotYetPaid	-513481	USD
CY2016	cpix	Purchases Of Intangible Assets Incurred But Not Yet Paid PurchasesOfIntangibleAssetsIncurredButNotYetPaid	-1179394	USD
CY2018	cpix	Deferred Offering Costs Includedin Accounts Payableand Other Accrued Expenses DeferredOfferingCostsIncludedinAccountsPayableandOtherAccruedExpenses	0	USD
CY2017	cpix	Deferred Offering Costs Includedin Accounts Payableand Other Accrued Expenses DeferredOfferingCostsIncludedinAccountsPayableandOtherAccruedExpenses	97254	USD
CY2016	cpix	Deferred Offering Costs Includedin Accounts Payableand Other Accrued Expenses DeferredOfferingCostsIncludedinAccountsPayableandOtherAccruedExpenses	0	USD
CY2018	us-gaap	Noncash Or Part Noncash Acquisition Other Liabilities Assumed1 NoncashOrPartNoncashAcquisitionOtherLiabilitiesAssumed1	14034000	USD
CY2017	us-gaap	Noncash Or Part Noncash Acquisition Other Liabilities Assumed1 NoncashOrPartNoncashAcquisitionOtherLiabilitiesAssumed1	0	USD
CY2016	us-gaap	Noncash Or Part Noncash Acquisition Other Liabilities Assumed1 NoncashOrPartNoncashAcquisitionOtherLiabilitiesAssumed1	0	USD
CY2015Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	76819783	USD
CY2016	us-gaap	Profit Loss ProfitLoss	-1003938	USD
CY2016	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	852102	USD
CY2016	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	-1026413	USD
CY2016	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	2520715	USD
CY2016Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	73120819	USD
CY2017	us-gaap	Profit Loss ProfitLoss	-8049815	USD
CY2017Q4	us-gaap	Cumulative Effect Of New Accounting Principle In Period Of Adoption CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption	1082924	USD
CY2017	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	1115063	USD
CY2017	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	372500	USD
CY2017	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	3719890	USD
CY2017Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	63921601	USD
CY2018	us-gaap	Profit Loss ProfitLoss	-7038772	USD
CY2018	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	1364698	USD
CY2018	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	200909	USD
CY2018	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	2877935	USD
CY2018Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	55570501	USD
CY2018	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-75704	USD
CY2017	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-71182	USD
CY2016	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-59255	USD
CY2018	us-gaap	Use Of Estimates UseOfEstimates	Use of EstimatesThe preparation of the consolidated financial statements in conformity with U.S. generally accepted accounting principles requires management of the Company to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the period. Actual results could differ from those estimates under different assumptions and conditions.
CY2018	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
CY2018	us-gaap	Production And Distribution Costs ProductionAndDistributionCosts	618756	USD
CY2017	us-gaap	Production And Distribution Costs ProductionAndDistributionCosts	621142	USD
CY2016	us-gaap	Production And Distribution Costs ProductionAndDistributionCosts	703353	USD
CY2018	us-gaap	Advertising Expense AdvertisingExpense	2219074	USD
CY2017	us-gaap	Advertising Expense AdvertisingExpense	2589185	USD
CY2016	us-gaap	Advertising Expense AdvertisingExpense	2626238	USD
CY2018	cpix	Payments For Asset Acquisitions PaymentsForAssetAcquisitions	2300000	USD
CY2018	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	40200832	USD
CY2017	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	40376563	USD
CY2016	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	32478185	USD
CY2018	cpix	Revenue Recognition Upfront Payment RevenueRecognitionUpfrontPayment	1500000	USD
CY2018	cpix	Revenue Recognition Potential Upfront Payments Relatedto Regulatory Approval RevenueRecognitionPotentialUpfrontPaymentsRelatedtoRegulatoryApproval	2400000	USD
CY2018	cpix	Revenue Recognition Potential Upfront Payment Relatedto Product Sales RevenueRecognitionPotentialUpfrontPaymentRelatedtoProductSales	4600000	USD
CY2018	cpix	Revenue Recognition Cumulative Upfront Payment RevenueRecognitionCumulativeUpfrontPayment	1500000	USD
CY2018	cpix	Revenue Recognition Milestone Payments RevenueRecognitionMilestonePayments	100000	USD
CY2018Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	18378450	USD
CY2017Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	3156002	USD
CY2018Q4	us-gaap	Other Inventory Materials Supplies And Merchandise Under Consignment OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment	937006	USD
CY2017Q4	us-gaap	Other Inventory Materials Supplies And Merchandise Under Consignment OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment	249964	USD
CY2018Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	8511887	USD
CY2017Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	3331882	USD
CY2018Q4	us-gaap	Inventory Gross InventoryGross	27827343	USD
CY2017Q4	us-gaap	Inventory Gross InventoryGross	6737848	USD
CY2018Q4	us-gaap	Inventory Noncurrent InventoryNoncurrent	15749000	USD
CY2017Q4	us-gaap	Inventory Noncurrent InventoryNoncurrent	0	USD
CY2018Q4	us-gaap	Inventory Net InventoryNet	12078343	USD
CY2017Q4	us-gaap	Inventory Net InventoryNet	6737848	USD
CY2018Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	300000	USD
CY2017Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	200000	USD
CY2018Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	3895923	USD
CY2017Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	3440354	USD
CY2018Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3124710	USD
CY2017Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2911472	USD
CY2018Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	771213	USD
CY2017Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	528882	USD
CY2018	cpix	Depreciation Including Amortization Related To Leasehold Improvements DepreciationIncludingAmortizationRelatedToLeaseholdImprovements	213237	USD
CY2017	cpix	Depreciation Including Amortization Related To Leasehold Improvements DepreciationIncludingAmortizationRelatedToLeaseholdImprovements	211532	USD
CY2016	cpix	Depreciation Including Amortization Related To Leasehold Improvements DepreciationIncludingAmortizationRelatedToLeaseholdImprovements	202868	USD
CY2018Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	33655099	USD
CY2017Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	21444545	USD
CY2018Q4	us-gaap	Goodwill Goodwill	784000	USD
CY2018	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2769466	USD
CY2017	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2436222	USD
CY2016	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2194039	USD
CY2018Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	3658612	USD
CY2018Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	3737638	USD
CY2018Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	3737638	USD
CY2018Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	3426180	USD
CY2018Q4	cpix	Finite Lived Intangible Assets Amortization Expense Year Fiveand After FiniteLivedIntangibleAssetsAmortizationExpenseYearFiveandAfter	19095031	USD
CY2018Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	33655099	USD
CY2017Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	618448	USD
CY2018Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	16710927	USD
CY2018Q4	cpix	Product Sales Related Liabilities Current ProductSalesRelatedLiabilitiesCurrent	5635972	USD
CY2017Q4	cpix	Product Sales Related Liabilities Current ProductSalesRelatedLiabilitiesCurrent	4683694	USD
CY2018Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1263426	USD
CY2017Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1032652	USD
CY2018Q4	cpix	Accrued Liabilities Stock Payable AccruedLiabilitiesStockPayable	1085400	USD
CY2017Q4	cpix	Accrued Liabilities Stock Payable AccruedLiabilitiesStockPayable	1324800	USD
CY2018Q4	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	2290000	USD
CY2017Q4	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	0	USD
CY2018Q4	cpix	Deferred Acquisition Liability Current DeferredAcquisitionLiabilityCurrent	5000000	USD
CY2017Q4	cpix	Deferred Acquisition Liability Current DeferredAcquisitionLiabilityCurrent	0	USD
CY2018Q4	cpix	Accrued Liabilities Inventory Purchases AccruedLiabilitiesInventoryPurchases	434405	USD
CY2017Q4	cpix	Accrued Liabilities Inventory Purchases AccruedLiabilitiesInventoryPurchases	1055220	USD
CY2018Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	1001724	USD
CY2017Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	8714814	USD
CY2018Q4	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	7212000	USD
CY2017Q4	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	0	USD
CY2018Q4	us-gaap	Deferred Compensation Liability Classified Noncurrent DeferredCompensationLiabilityClassifiedNoncurrent	1588123	USD
CY2017Q4	us-gaap	Deferred Compensation Liability Classified Noncurrent DeferredCompensationLiabilityClassifiedNoncurrent	1599960	USD
CY2018Q4	us-gaap	Accounts Payable And Accrued Liabilities Noncurrent AccountsPayableAndAccruedLiabilitiesNoncurrent	519020	USD
CY2017Q4	us-gaap	Accounts Payable And Accrued Liabilities Noncurrent AccountsPayableAndAccruedLiabilitiesNoncurrent	216008	USD
CY2018Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	9319143	USD
CY2017Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1815968	USD
CY2018Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2018Q1	cpix	Stock Issued During Period Shelf Registration Proceeds From Saleof Corporate Securities StockIssuedDuringPeriodShelfRegistrationProceedsFromSaleofCorporateSecurities	100000000	USD
CY2016	us-gaap	Noncontrolling Interest Increase From Sale Of Parent Equity Interest NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest	1000000	USD
CY2015Q1	us-gaap	Minority Interest Ownership Percentage By Parent MinorityInterestOwnershipPercentageByParent	0.85
CY2014Q2	us-gaap	Payments To Acquire Interest In Subsidiaries And Affiliates PaymentsToAcquireInterestInSubsidiariesAndAffiliates	1000000.0	USD
CY2014Q2	cpix	Loans Forgivenin Exchange For Share Issued Amount LoansForgiveninExchangeForShareIssuedAmount	2400000	USD
CY2018	us-gaap	Net Income Loss NetIncomeLoss	-6963068	USD
CY2017	us-gaap	Net Income Loss NetIncomeLoss	-7978633	USD
CY2016	us-gaap	Net Income Loss NetIncomeLoss	-944683	USD
CY2018	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	15614052	shares
CY2017	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	15911577	shares
CY2016	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	16236525	shares
CY2018	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2017	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2016	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2018	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	15614052	shares
CY2017	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	15911577	shares
CY2016	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	16236525	shares
CY2018	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	41650	shares
CY2017	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	18325	shares
CY2016	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	13300	shares
CY2018Q4	cpix	Deferred Tax Assets Operating Loss Carryforwards And Tax Credit Carryforwards DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwards	16410403	USD
CY2017Q4	cpix	Deferred Tax Assets Operating Loss Carryforwards And Tax Credit Carryforwards DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwards	15295547	USD
CY2018Q4	cpix	Deferred Tax Assets Property And Equipment And Intangibles DeferredTaxAssetsPropertyAndEquipmentAndIntangibles	236318	USD
CY2017Q4	cpix	Deferred Tax Assets Property And Equipment And Intangibles DeferredTaxAssetsPropertyAndEquipmentAndIntangibles	232667	USD
CY2018Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	251068	USD
CY2017Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	129180	USD
CY2018Q4	cpix	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Reserves For Expired Product DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReservesForExpiredProduct	558484	USD
CY2017Q4	cpix	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Reserves For Expired Product DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReservesForExpiredProduct	538141	USD
CY2018Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	193150	USD
CY2017Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	173885	USD
CY2018Q4	cpix	Deferred Tax Assets Deferred Charges DeferredTaxAssetsDeferredCharges	910577	USD
CY2017Q4	cpix	Deferred Tax Assets Deferred Charges DeferredTaxAssetsDeferredCharges	624367	USD
CY2018Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	884049	USD
CY2017Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	793206	USD
CY2018Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	19444049	USD
CY2017Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	17786993	USD
CY2018Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	1974787	USD
CY2017Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	2067548	USD
CY2018Q4	cpix	Net Deferred Tax Assets Gross NetDeferredTaxAssetsGross	17469262	USD
CY2017Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	15632235	USD
CY2017Q4	cpix	Net Deferred Tax Assets Gross NetDeferredTaxAssetsGross	15719445	USD
CY2018Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	17382052	USD
CY2018Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	87210	USD
CY2017Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	87210	USD
CY2018	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	USD
CY2017	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	USD
CY2016	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	-867041	USD
CY2018	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	16636	USD
CY2017	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	59243	USD
CY2016	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	-83463	USD
CY2018	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	16636	USD
CY2017	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	59243	USD
CY2016	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	-950504	USD
CY2018	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0	USD
CY2017	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	3682772	USD
CY2016	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	537965	USD
CY2018	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0	USD
CY2017	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	432874	USD
CY2016	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	81615	USD
CY2018	us-gaap	Deferred Other Tax Expense Benefit DeferredOtherTaxExpenseBenefit	0	USD
CY2017	us-gaap	Deferred Other Tax Expense Benefit DeferredOtherTaxExpenseBenefit	4115646	USD
CY2016	us-gaap	Deferred Other Tax Expense Benefit DeferredOtherTaxExpenseBenefit	619580	USD
CY2018	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	16636	USD
CY2017	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	4174889	USD
CY2016	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-330924	USD
CY2018	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2017	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.34
CY2016	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.34
CY2018	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.04
CY2017	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.04
CY2016	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.04
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	-0.01
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	-0.01
CY2016	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	-0.05
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.25
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-1.48
CY2016	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.15
CY2018	cpix	Effective Income Tax Rate Reconciliation Tax Cutsand Jobs Actof2017 Percent EffectiveIncomeTaxRateReconciliationTaxCutsandJobsActof2017Percent	0
CY2018Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	2400000	USD
CY2017	cpix	Effective Income Tax Rate Reconciliation Tax Cutsand Jobs Actof2017 Percent EffectiveIncomeTaxRateReconciliationTaxCutsandJobsActof2017Percent	0.02
CY2016	cpix	Effective Income Tax Rate Reconciliation Tax Cutsand Jobs Actof2017 Percent EffectiveIncomeTaxRateReconciliationTaxCutsandJobsActof2017Percent	0
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	-0.01
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	0.01
CY2016	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	-0.02
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.02
CY2016	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.01
CY2018	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0
CY2017	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-1.08
CY2016	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.25
CY2017	cpix	Tax Cuts And Jobs Act Of2017 Income Tax Expense Benefit TaxCutsAndJobsActOf2017IncomeTaxExpenseBenefit	-100000	USD
CY2018	cpix	Share Based Compensation Arrangement By Share Based Payment Award Number Of Plans Available For Future Grants ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlansAvailableForFutureGrants	2	plan
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	5800	shares
CY2018	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y7M6D
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	13.00
CY2016	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P1Y10M24D
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0	USD
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2017	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
CY2017	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
CY2017	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	0	shares
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	0
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	5800	shares
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	13.00
CY2017	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P0Y10M24D
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0	USD
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2018	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
CY2018	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
CY2018	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	0	shares
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	0
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	5800	shares
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	13.00
CY2018	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P0Y1M6D
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0	USD
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	5800	shares
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	13.00
CY2018	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P0Y1M6D
CY2018Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	0	USD
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	0	USD
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	0	USD
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	0	USD
CY2018	cpix	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageGrantDateFairValue	0
CY2017	cpix	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageGrantDateFairValue	0
CY2016	cpix	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageGrantDateFairValue	0
CY2018	cpix	Defined Contribution Plan Eligibility Minimum Employee Age DefinedContributionPlanEligibilityMinimumEmployeeAge	P21Y
CY2018	cpix	Defined Contribution Plan Eligibility Minimum Employee Service Time For Participation Eligibility DefinedContributionPlanEligibilityMinimumEmployeeServiceTimeForParticipationEligibility	six months
CY2018	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	50000	USD
CY2018Q4	us-gaap	Deferred Compensation Liability Current And Noncurrent DeferredCompensationLiabilityCurrentAndNoncurrent	1600000	USD
CY2018Q4	us-gaap	Deferred Compensation Plan Assets DeferredCompensationPlanAssets	2300000	USD
CY2018	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	1136610	USD
CY2017	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	1074437	USD
CY2016	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	1150614	USD
CY2018	us-gaap	Operating Leases Rent Expense Sublease Rentals1 OperatingLeasesRentExpenseSubleaseRentals1	662358	USD
CY2017	us-gaap	Operating Leases Rent Expense Sublease Rentals1 OperatingLeasesRentExpenseSubleaseRentals1	573494	USD
CY2016	us-gaap	Operating Leases Rent Expense Sublease Rentals1 OperatingLeasesRentExpenseSubleaseRentals1	646235	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due Future Minimum Sublease Rentals OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentals	300000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	959902	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	980720	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	1001603	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	871969	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	44508	USD
CY2018Q4	cpix	Operating Leases Future Minimum Payments Due In Five Years And Thereafter OperatingLeasesFutureMinimumPaymentsDueInFiveYearsAndThereafter	0	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	3858702	USD
CY2018Q4	us-gaap	Trading Securities TradingSecurities	8290679	USD
CY2017Q4	us-gaap	Trading Securities TradingSecurities	4672476	USD
CY2018Q1	us-gaap	Revenues Revenues	8587605	USD
CY2018Q2	us-gaap	Revenues Revenues	10163724	USD
CY2018Q3	us-gaap	Revenues Revenues	8492530	USD
CY2018Q4	us-gaap	Revenues Revenues	13497906	USD
CY2018	us-gaap	Revenues Revenues	40741765	USD
CY2018Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-2452222	USD
CY2018Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-868978	USD
CY2018Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-1806883	USD
CY2018Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-2262689	USD
CY2018	us-gaap	Operating Income Loss OperatingIncomeLoss	-7390772	USD
CY2018Q1	us-gaap	Net Income Loss NetIncomeLoss	-2379239	USD
CY2018Q2	us-gaap	Net Income Loss NetIncomeLoss	-720688	USD
CY2018Q3	us-gaap	Net Income Loss NetIncomeLoss	-1643044	USD
CY2018Q4	us-gaap	Net Income Loss NetIncomeLoss	-2220097	USD
CY2018	us-gaap	Net Income Loss NetIncomeLoss	-6963068	USD
CY2018Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.15
CY2018Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.05
CY2018Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.11
CY2018Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.14
CY2018	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.45
CY2018Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.15
CY2018Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.05
CY2018Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.11
CY2018Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.14
CY2018	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.45
CY2017Q1	us-gaap	Revenues Revenues	9636755	USD
CY2017Q2	us-gaap	Revenues Revenues	8667127	USD
CY2017Q3	us-gaap	Revenues Revenues	11196961	USD
CY2017Q4	us-gaap	Revenues Revenues	11649288	USD
CY2017	us-gaap	Revenues Revenues	41150131	USD
CY2017Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-657802	USD
CY2017Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-1680871	USD
CY2017Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-839349	USD
CY2017Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-903326	USD
CY2017	us-gaap	Operating Income Loss OperatingIncomeLoss	-4081348	USD
CY2017Q1	us-gaap	Net Income Loss NetIncomeLoss	-1274446	USD
CY2017Q2	us-gaap	Net Income Loss NetIncomeLoss	-5160611	USD
CY2017Q3	us-gaap	Net Income Loss NetIncomeLoss	-743031	USD
CY2017Q4	us-gaap	Net Income Loss NetIncomeLoss	-800545	USD
CY2017	us-gaap	Net Income Loss NetIncomeLoss	-7978633	USD
CY2017Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.08
CY2017Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.32
CY2017Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.05
CY2017Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.05
CY2017	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.50
CY2017Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.08
CY2017Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.32
CY2017Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.05
CY2017Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.05
CY2017	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.50
CY2017	us-gaap	Valuation Allowances And Reserves Period Increase Decrease ValuationAllowancesAndReservesPeriodIncreaseDecrease	4202854	USD
CY2017	cpix	Tax Cutsand Jobs Actof2017 Changein Tax Rate Deferred Tax Asset Income Tax Expense Benefit TaxCutsandJobsActof2017ChangeinTaxRateDeferredTaxAssetIncomeTaxExpenseBenefit	4867893	USD

Files In Submission

Name	View Source	Status
0001628280-19-002785-index-headers.html	Edgar Link	pending
0001628280-19-002785-index.html	Edgar Link	pending
0001628280-19-002785.txt	Edgar Link	pending
0001628280-19-002785-xbrl.zip	Edgar Link	pending
a2018-10kxexhibit1011a.htm	Edgar Link	pending
a2018-10kxexhibit1012m.htm	Edgar Link	pending
a2018-10kxexhibit1013l.htm	Edgar Link	pending
a2018-10kxexhibit1014m.htm	Edgar Link	pending
a2018-10kxexhibit1015j.htm	Edgar Link	pending
a2018-10kxexhibit231co.htm	Edgar Link	pending
a2018-10kxexhibit232co.htm	Edgar Link	pending
a2018-10kxexhibit311.htm	Edgar Link	pending
a2018-10kxexhibit312.htm	Edgar Link	pending
a2018-10kxexhibit321.htm	Edgar Link	pending
cpix-20181231.htm	Edgar Link	pending
cpix-20181231.xsd	Edgar Link	pending
cpix-20181231_cal.xml	Edgar Link	unprocessable
cpix-20181231_def.xml	Edgar Link	unprocessable
cpix-20181231_g1.jpg	Edgar Link	pending
cpix-20181231_htm.xml	Edgar Link	completed
cpix-20181231_lab.xml	Edgar Link	unprocessable
cpix-20181231_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CPIX
CUMBERLAND PHARMACEUTICALS INC Stock $cpix

2017 Q4 Form 10-K Financial Statement

#000162828019002785 Filed on March 12, 2019

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CPIX CUMBERLAND PHARMACEUTICALS INC Stock $cpix

2017 Q4 Form 10-K Financial Statement

#000162828019002785 Filed on March 12, 2019

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CPIX
CUMBERLAND PHARMACEUTICALS INC Stock $cpix